Oct 21, 2026 06:07AM
Oct 21, 2026 06:05AM
Oct 19, 2026 07:00AM
Oct 5, 2026 07:01AM
Oct 5, 2026 07:00AM
Oct 2, 2026 06:04AM
Oct 2, 2026 02:30AM Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
Sep 29, 2026 12:12PM
Sep 28, 2026 05:33PM
Sep 28, 2026 05:30PM
Sep 15, 2026 06:01AM
Sep 15, 2026 06:00AM
Sep 13, 2026 07:47PM
Sep 13, 2026 07:00AM Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study
Aug 25, 2026 06:39PM
Aug 25, 2026 06:00PM
Aug 25, 2026 07:02AM
Aug 25, 2026 07:00AM
Aug 12, 2026 09:22AM
Aug 12, 2026 09:22AM
Aug 6, 2026 06:55AM H.C. Wainwright Reiterates Neutral Rating on Summit Therapeutics plc (SMMT)
Aug 5, 2026 07:00AM
Jul 23, 2026 04:06PM
Jul 23, 2026 04:05PM
Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Jul 22, 2026 06:30AM
Jul 22, 2026 06:30AM Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis from Global Phase III HARMONi Study
Jun 1, 2026 02:53AM
May 31, 2026 09:06AM
May 30, 2026 08:00AM
May 22, 2026 06:35AM
Apr 30, 2026 04:32PM
Mar 27, 2026 08:16AM
Mar 27, 2026 08:15AM Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
Feb 26, 2026 06:45PM
Feb 23, 2026 04:05PM
Feb 2, 2026 06:50AM
Jan 30, 2026 05:41AM
Jan 29, 2026 07:30AM
Jan 29, 2026 07:30AM

15,963 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All